JFL Life Sciences Ltd

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

At Rs 9.90, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JFL Life Sciences Ltd locked at its upper circuit of 4.76% on 2 Jun 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 9.45, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JFL Life Sciences Ltd locked at its upper circuit of 5.0% on 1 Jun 2026, with buyers queuing and no sellers willing to part with shares.

JFL Life Sciences Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹57.00 crores, reported a dramatic 134.91% quarter-on-quarter revenue surge to ₹63.05 crores in Q4 FY26, marking the company's strongest quarterly sales performance on record. However, this topline expansion came at a significant cost to profitability, with operating margins contracting sharply to 5.57% from 12.48% in the previous quarter, raising critical questions about the sustainability and quality of this growth trajectory.

At Rs 9.10, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JFL Life Sciences Ltd locked at its upper circuit of 3.45% on 29 May 2026, with buyers queuing and no sellers willing to part with shares.

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

At Rs 8.80, sellers were still queuing — but there were no buyers willing to take the other side. JFL Life Sciences Ltd locked at its lower circuit of 4.86% on 26 May 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 Jan 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 18 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

At Rs 9.20, sellers were still queuing — but there were no buyers willing to take the other side. JFL Life Sciences Ltd locked at its lower circuit of 4.66% on 12 May 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a thinly traded micro-cap stock.

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 Jan 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

At Rs 9.35, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JFL Life Sciences Ltd locked at its upper circuit of 4.47% on 05 May 2026, with buyers queuing and no sellers willing to part with shares.

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

At Rs 9.15, sellers were still queuing — but there were no buyers willing to take the other side. JFL Life Sciences Ltd locked at its lower circuit of 4.69% on 20 Apr 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.

JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

At Rs 8.95, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. JFL Life Sciences Ltd locked at its upper circuit of 4.68% on 6 Apr 2026, with buyers queuing and no sellers willing to part with shares.

At Rs 8.55, JFL Life Sciences Ltd locked at its lower circuit on 2 Apr 2026, reflecting a 4.47% decline within a 5% price band. Sellers were lined up to exit, but no buyers emerged to absorb the supply, resulting in a frozen price and unfilled sell orders.